Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year  | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2004 | FL-AG | $807,826 |
| MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | pharmaceuticals | environmental violation | 2005 | EPA | $21,125 |
| AstraZeneca | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | employment discrimination | 2008 | private lawsuit-state | $350,000 |
| AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | consumer protection violation | 2010 | KY-AG | $5,391,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
| AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| AstraZeneca | AstraZeneca | pharmaceuticals | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $198,000,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | employment discrimination | 2011 | OFCCP | $250,000 |
| AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
| AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
| ALEXION PHARMACEUTICALS, INC. | AstraZeneca | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $8,213 |
| AstraZeneca | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
| AstraZeneca PLC | AstraZeneca | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $5,522,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
| Alexion Pharmaceuticals Inc. | AstraZeneca | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $13,000,000 |
| Alexion Pharmaceuticals Inc. | AstraZeneca | pharmaceuticals | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | employment discrimination | 2021 | OFCCP | $560,000 |
| ASTRAZENECA PLP | AstraZeneca | pharmaceuticals | environmental violation | 2021 | EPA | $18,960 |
